The Telegram - News - Canada - World - Business

Article

Print
Send to a friend
Comment (0)

Bayer earnings down on litigation provisions, but revenue up and company raises 2012 outlook

Published on July 31, 2012; Published on July 31, 2012

Topics :: Bayer AG , BERLIN

BERLIN - Bayer AG says its second-quarter earnings were a third lower than last year because of one-time charges that included money set aside to deal with litigation linked to a contraceptive, but its revenues rose 10 per cent and the company raised its full-year outlook.

The pharmaceutical and chemical company on Tuesday reported net earnings of €494 million ($606 million) for April-June — down from €747 million a year earlier. Revenues climbed to €10.18 billion from €9.25 billion.

Earnings were weighed down by special items totalling €762 million. That included €496 million in risk provisions for "all litigations in connection with the oral contraceptive Yasmin/YAZ of which Bayer is currently aware and which it considers to be worthy of settlement."

Bayer says it is raising its full-year revenue and pre-tax earnings guidance.

©

Rate
Top of the page

Submit a comment

Submit a comment Your name* Email* (we keep all emails private) Write your comment here*

Agreement

We ask that users remain courteous. You may not post insulting, discriminatory or inappropriate content, which may be removed at our discretion. We are not responsible for user content and opinions. Use of this site as well as content submission & ownership are governed by our Conditions of Use and Privacy Policy.

Member organizations should be non-profit in nature, and promote legal activities. Any organization found promoting illegal activities or commercial products or services will be deleted from the site.

I agree with these conditions.